New York, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

The Future of Outpatient Cancer Surgery Takes Shape with New, First-of-Its-Kind Facility

A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center (JRSC), opened by Memorial Sloan Kettering, exemplifies that...
28-Dec-2015 10:05 AM EST Add to Favorites

MSK Studies Highlight Potential of Liquid Biopsy at 2015 San Antonio Breast Cancer Symposium

Information gleaned from a liquid biopsy may help predict how individual women with advanced breast cancer will respond to certain therapies as well as reveal genetic mutations that can impact prognosis, according to two new studies presented this...
11-Dec-2015 11:05 AM EST Add to Favorites

Study Examines Cancer-Care Outcomes Among US Hospitals

A new JAMA Oncology study from Memorial Sloan Kettering Cancer Center finds that risk-adjusted Medicare claims data — without information about the cancer stage of individual patients — may be sufficient to calculate the long-term survival rates...
7-Oct-2015 4:00 PM EDT Add to Favorites

Three Young Investigators Named Winners of 2015 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research.
29-Sep-2015 10:05 AM EDT Add to Favorites

Memorial Sloan Kettering Cancer Center Researchers Publish Landmark “Basket Study”

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors...
19-Aug-2015 5:05 PM EDT Add to Favorites

Lehigh Valley Health Network to Join Memorial Sloan Kettering Cancer Alliance

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment...
4-Aug-2015 2:30 PM EDT Add to Favorites

Immunotherapy Combo Increases Progression-Free Survival in Advanced Melanoma Patients

Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab and ipilimumab or nivolumab alone significantly increases progression-free survival over using ipilimumab alone, according to Memorial Sloan Kettering...
31-May-2015 7:30 AM EDT Add to Favorites

Memorial Sloan Kettering Cancer Center Receives Record Gift of $150 Million from David Koch for Innovative Patient Care Facility

Memorial Sloan Kettering Cancer Center (MSK) announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with...
20-May-2015 8:05 AM EDT Add to Favorites

Our YouTube Videos